Literature DB >> 5014778

Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite.

D L Hill, W R Laster, R F Struck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5014778

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  20 in total

1.  Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide.

Authors:  E J Valente; K K Chan; K L Servis
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

2.  Formation of 4-ketocyclophosphamide by the oxidation of cyclophosphamide with KMnO4.

Authors:  M Jarman
Journal:  Experientia       Date:  1973

3.  The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide.

Authors:  M C Berenbaum; W A Cope; J A Double
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

4.  Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.

Authors:  Fei Li; Andrew D Patterson; Constance C Höfer; Kristopher W Krausz; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

5.  Studies on the mechanism of hepatic microsomal N-oxide formation. The role of cytochrome P-450 and mixed-function amine oxidase in the N-oxidation of NN-dimethylaniline.

Authors:  P Hlavica; M Kehl
Journal:  Biochem J       Date:  1977-06-15       Impact factor: 3.857

6.  Haemodialysis during cyclophosphamide treatment.

Authors:  M R Bending; R E Finch
Journal:  Br Med J       Date:  1978-04-29

Review 7.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

8.  Preclinical pharmacokinetics and stability of isophosphoramide mustard.

Authors:  J J Zheng; K K Chan; F Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  The metabolism of nicotine-delta 1'(5')-iminium ion, in vivo and in vitro.

Authors:  J W Gorrod; A R Hibberd
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

10.  Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma.

Authors:  P M Wilkinson; P A O'Neill; N Thatcher; S B Lucas
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.